Cleveland Clinic Abu Dhabi’s Heart and Vascular Experts Share Insights at 49th Annual Cardiocon Event

Cleveland Clinic Abu Dhabi’s Heart and Vascular Experts Share Insights at 49th Annual Cardiocon Event

Experts Outline Latest Innovations in Cardiovascular Medicine and Surgery

Islamabad: 25th November 2019 – A full delegation of cardiovascular physicians and surgeons from the prestigious Cleveland Clinic Abu Dhabi, a leading center of medical excellence in the United Arab Emirates, are highlighting the latest innovations in heart and vascular health at the 49th annual Cardiocon event this week.

The delegation is being led by two of the most seasoned heart and vascular physicians at Cleveland Clinic Abu Dhabi, Dr. E. Murat Tuzcu, Chief Academic Officer and the Chief of Cardiovascular Medicine in the hospital’s Heart & Vascular Institute, and Dr. Faisal Hasan, a seasoned Interventional Cardiologist and Vice Chair of Cardiovascular Medicine at Cleveland Clinic Abu Dhabi.

Dr. Tuzcu, speaking for the first time in Pakistan, is an internationally recognized expert in the emerging field of heart valve repair and replacement and treats patients from all around the world.  Dr. Hasan is specialized in minimally invasive complex cardiac and vascular procedures, following his initial medical training at the Aga Khan University Medical College in Karachi.

Physicians from the hospital will cover a range of topics, including treatments for high risk patients, structural heart disease, and new vascular approaches for saving the limbs of patients at risk of amputation.

Cardiocon enables the team from Cleveland Clinic Abu Dhabi to exchange ideas and best practice with peers from Pakistan’s medical community about the changing needs of the patient populations in both markets.

The Heart & Vascular Institute is one of the five Centers of Excellence at Cleveland Clinic Abu Dhabi. Led by some of the world’s most respected physicians and surgeons, it offers basic diagnostic to cutting-edge treatments including minimally invasive and robotic cardiac surgery.  The Institute was the first in the Middle East to introduce transcatheter aortic valve replacement (TAVR) as an alternative to traditional open-heart valve replacement surgery – TAVR is one of the key innovations being discussed at Cardiocon this week.

The 49th annual Cardiocon event is themed around ‘Catching Up on the Recent Advancements in Cardiology in a Developing Country’ and takes place November 22-24 in Islamabad.